THE 2-MINUTE RULE FOR SYNTHETIC CANNABINOIDS EAM2201

In vitro Opposition binding experiments verified that MAM-2201 and AM-2201 have nanomolar affinity for both CD-1 murine and human CB1 and CB2 receptors, with choice to the CB1 receptor. In agreement Together with the in vitro binding data, in vivo studies confirmed that MAM-2201 induces Visible, acoustic, and tactile impairments which were absolute